Comparative features of hepatitis C virus infection in humans and chimpanzees

Springer Seminars in Immunopathology

Volumn 19, Issue 1, 1997, Pages 85-98

  Walker, Christopher M ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR IMMUNITY; CHIMPANZEE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMORAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS IMMUNITY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS, CHRONIC; HUMANS; IMMUNITY, CELLULAR; LIVER; PAN TROGLODYTES; SPECIES SPECIFICITY;

EID: 0030760401     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00945027     Document Type: Review

References (93)

1. Abe K, Inchauspe G, Shikata T, Prince AM (1991) Three different patterns of hepatitis C virus infection in chimpanzees. Hepatology 15: 690
2. Agnello V, Muchmore E, Abel G, Knight GB (1997) Evidence for a "latent" phase in chronic hepatitis C virus infection in the chimpanzee. Abstracts of the 4th International Meeting on Hepatitis C Virus and Related Viruses, Kyoto, Japan. Fujitsu Aprico, Tokyo
3. Alberti A, Chemello L, Cavalletto D, Tagger A, Dal Canton A, Bizzaro N (1991) Antibody to hepatitis C virus and liver disease in volunteer blood donors. Ann Intern Med 114: 1010
4. Alter HJ, Purcell RH, Holland PV, Popper H (1978) Transmissible agent in non-A, non-B hepatitis. Lancet 1: 459
5. Alter HJ, Sanchez-Pescador R, Urdea MS, Wilber JC, Lagier RJ, Di Bisceglie AM, Shih JW, Neuwald PD (1995) Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA. J Viral Hepat 2: 121
6. Ballardini G, Groff P, Pontisso P, Giostra F, Francesconi R, Lenzi M, Zauli D, Alberti A, Bianchi FB (1995) Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intracellular adhesion-1 molecules J Clin Invest 95: 2067
7. Barnaba V, Franco A, Alberti A, Benvenuto R, Balsano F (1990) Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes. Nature 345: 258
8. Battegay M, Fikes J, Di Bisceglie AM, Wentworth PA, Sette A, Celis E (1995) Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J Virol 69: 2462
9. Beach MJ, Meeks EL, Mimms LT, Vallari D, DuCharme L, Speibring J, Taskar S, Schleicher JB, Krawczynski K, Bradley DW (1992) Temporal relationships of hepatitis C virus RNA and antibody responses following experimental infection of chimpanzees. J Med Virol 36: 226
10. Botarelli P, Brunetto MR, Minutello MA, Calvo P, Unutmaz D, Weiner AJ (1993) T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 104: 580
11. Bradley DW, Maynard JE, Popper H, Ebert JW, Cook EH, Fields HA, Kemler BJ (1981) Persistent non-A, non-B hepatitis in experimentally infected chimpanzees. J Infect Dis 143: 210
12. Bradley DW, Krawczynski K, Ebert JW, McCaustland KA, Choo Q-L, Houghton MA, Kuo G (1990) Parenterally transmitted non-A, non-B hepatitis: virus-specific antibody response patterns in hepatitis C virus-infected chimpanzees. Gastroenterology 99: 1054
13. Bradley DW, Krawczynski K, Beach MJ, Purdy MA (1991) Non-A, non-B hepatitis: toward the discovery of hepatitis C and E viruses. Semin Liver Dis 11: 128
14. Brillanti S, Foli M, Gaiani S, Masci C, Miglioli M, Barbara L (1993) Persistent hepatitis C viraemia without liver disease. Lancet 341: 464
15. Bukh J, Miller RH, Purcell RH (1995) Genetic heterogenicity of hepatitis C virus: Quasispecies and genotypes. Semin Liver Dis 15: 41
16. Cerny A, McHutchison JG, Pasquinelli C, Brown ME, Brothers MA, Grabscheid B (1995) Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J Clin Invest 95: 521
17. Chien DY, Choo Q-L, Ralston R, Spaete R, Tong M, Houghton M, Kuo G (1993) Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet 342: 933
18. Choo S-H, So H-S, Cho JM, Ryu W-S (1995) Association of hepatitis C virus particles with immunoglobulin: a mechanism for persistent infection. J Gen Virol 76: 2337
19. Choo Q-L, Kuo G, Weiner A, Wang K-S, Overby L, Bradley D, Houghton M (1992) Identification of the major, parenteral non-A, non-B hepatitis agent (hepatitis C virus) using a recombinant cDNA approach. Semin Liver Dis 12: 279
20. Choo Q-L, Kuo G, Ralston R, Weiner A, Chien D, Van Nest G, Han J, Berger K, Thudium K, Kuo C, Kansopon J, McFarland J, Tabrizi A, Ching K, Moss B, Cummins LB, Houghton M, Muchmore E (1994) Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci USA 91: 1294
21. Diepolder HM, Zachoval R, Hoffman RM, Wierenga EA, Santantonio T, Jung M-C (1995) Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346: 1006
22. Erickson AL, Houghton M, Choo Q-L, Weiner AJ, Ralston R, Muchmore E (1993) Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. J Immunol 151: 4189
23. Esteban JI, L'opez-Talavera JC, Genescó J, Madoz P, Viladomiu L, Muniz E (1991) High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Intern Med 115: 443
24. Farci P, Alter HJ, Wong D, Miller RH, Shih JW, Jett B, Purcell RH (1991) A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med 325: 98
25. Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, Desai SM, Miller RH, Ogata N, Purcell RH (1992) Lack of protective immunity against reinfection with hepatitis C virus. Science 258: 135
26. Farci P, London WT, Wong DC, Dawson GJ, Vallari DS, Engle R, Purcell RH (1992) The natural history of infection with hepatitis C virus (HCV) in chimpanzees: comparion of serologic responses measured with first- and second-generation assays and relationship to HCV viremia. J Infect Dis 165: 1006
27. Farci P, Alter HJ, Wong DC, Miller RH, Govindarajan S, Engle R, Shapiro M, Purcell RH (1994) Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci USA 91: 7792
28. Farci P, Shimoda A, Wong D, Cabezon T, De Gioannis D, Strazzera A, Shimizu Y, Shapiro M, Alter HJ, Purcell RH (1996) Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein Proc Natl Acad Sci USA 93: 15394
29. Feinstone SM, Alter HJ, Dienes HP, Shimizu Y, Popper H, Blackmore D, Sly D, London WT, Purcell RH (1981) Non-A, non-B hepatitis in chimpanzees and marmosets. J Infect Dis 144: 588.
30. Ferrari C, Valli A, Galati L, Penna A, Scaccaglia P, Giuberti T (1994) T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 1994 19: 286
31. Hilfenhaus J, Krupka U, Nowak T, Cummins LB, Fuchs K, Roggendorf M (1992) Follow-up of hepatitis C virus infection in chimpanzees: determination of viraemia and specific humoral immune response. J Gen Virol 73: 1015
32. + T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology 21: 632
33. Hollinger FB, Gitnick GL, Aach RD, Szmuness W, Mosley JW, Stevens CE (1978) Non-A, non-B hepatitis transmission in chimpanzees: a project of the transfusion-transmitted viruses study group. Intervirology 10: 60
34. Jackson DR, Tabor E, Gerety, RF (1979) Acute non-A, non-B hepatitis: specific ultrastructural alterations in endoplasmic reticulum of infected hepatocytes Lancet 1: 1249
35. Kaneko T, Nakamura I, Kita H, Hiroishi K, Moriyama T, Imawari M (1996) Three new cytotoxic T cell epitopes identified within the hepatitis C virus nucleoprotein. J Gen Virol 77: 1305
36. Kato N, Sekiya H, Ootsuyama Y, Nakazawa T, Hijikata M, Ohkoshi S, Shimitohno K (1993) Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol 67: 3923
37. Kato T, Esumi M, Yamashita S, Abe K, Shikata T (1992) Interferon-inducible gene expression in chimpanzee liver infected with hepatitis C virus. Virology 190: 856
38. Kita H, Moriyama T, Kaneko T, Harase I, Nomura M, Miura H, Nakamura I (1993) HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology 18: 1039
39. Kita H, Hiroishi K, Moriyama T, Okamoto H, Kaneko T, Ohnishi S (1995) A minimal and optimal cytotoxic T cell epitope within hepatitis C virus nucleoprotein. J Gen Virol 76: 3189
40. + cytotoxic T cells from two chronically infected chimpanzees. J Exp Med 183: 1761
41. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R (1992) Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 149: 3339
42. Koziel MJ, Dudley D, Afdhal N, Choo Q-L, Houghton M, Ralston R (1993) Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol 67: 7522
43. Koziel MJ, Dudley D, Afdhal N, Grakoui A, Rice CM, Choo Q-L (1995) HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest 96: 2311
44. Krawczynski K, Beach MJ, Bradley DW, Kuo G, Di Bisceglie AM, Houghton M (1992) Hepatitis C antigen in hepatocytes: immunomorphologic detection and identification. Gastroenterology 103: 622
45. Krawczynski K, Beach M, Bradley DW, Meeks E, Spelbring JE (1992) Immunosuppression and pathogenic studies of acute hepatitis C virus (HCV) infection in chimpanzees. Hepatology 2: 131A
46. Kumar U, Monjardino J, Thomas HC (1994) Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patients. Gastroenterology 106: 1072
47. Lai ME, Mazzoleni AP, Argiolu F, De Virgilis S, Balestrieri A, Purcell RH, Cao A, Farci P (1994) Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 343: 388
48. Lanford RE, Notvall L, Barbosa LH, Eichberg JW (1991) Evaluation of a chimpanzee colony for antibodies to hepatitis C virus. J Med Virol 34: 148
49. Lechmann M, Ihlenfeldt HG, Braunschweiger I, Giers G, Jung G, Matz B (1996) T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus - Positive blood donors without viremia. Hepatology 24: 790
50. Leroux-Roels G, Esquivel CA, DeLeys R, Stuyver L, Elewaut A, Philippé J (1996) Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon-alfa. Hepatology 23: 8
51. + T cells in chronic hepatitis C: immunodominant epitopes, HLA-restriction and functional significance. Liver 16: 174
52. Mink MA, Benichou S, Madaule P, Tiollais P, Prince AM, Inchauspe G (1994) Characterization of mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library. Virology 200: 246
53. + T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med 178: 17
54. Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, Mori C (1996) Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 98: 706
55. Muchmore E, Popper H, Peterson DA, Miller MF, Lieberman HM (1988) Non-A, non-B hepatitis-related hepatocellular carcinoma in a chimpanzee. J Med Primatol 17: 235
56. Negro F, Pacchioni D, Shimizu Y, Miller RH, Bussolati G, Purcell RH (1992) Detection of intrahepatic replication of hepatitis C virus RNA by in situ hybridization and comparison with histopathology. Proc Natl Acad Sci USA 89: 2247
57. Ogata N, Alter HJ, Miller RH, Purcell RH (1991) Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci USA 88: 3392
58. Okamoto H, Kojima M, Okada S-I, Yoshizawa H, Iizuka H, Tanaka T, Muchmore EE, Peterson DA, Ito Y, Mishiro S (1992) Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability. Virology 190: 894
59. Okamoto H, Mishiro S, Tokita H, Tsuda F, Miyakawa Y, Mayumi M (1994) Superinfection of chimpanzees carrying hepatitis C virus of genotype II/1b with that of genotype III/2a or I/1a. Hepatology 20: 1131
60. Pfeifer AM, Thomssen R, Legler K, Borrcher U, Gerlich W, Weinmann, O, Kling O (1980) Experimental non-A, non-B hepatitis: four types of cytoplasmic alterationin hepatocytes of infected chimpanzees. Virchows Arch [B] 33: 233
61. Planz O, Seiler P, Hengartner H, Zinkemagel RM (1996) Specific cytotoxic T cells eliminate cells producing neutralizing antibodies. Nature 382: 726
62. Popper H, Dienstag JI, Feinstone SM, Alter HJ, Purcell RH (1980) The pathology of viral hepatitis in chimpanzees. Virchows Archiv [A] 387: 91
63. Prince AM, Brotman B (1994) The biology of hepatitis C virus infection. lessons learned from chimpanzees. Curr Stud Hematol Blood Transfus 61: 195
64. Prince AM, Brotman B, Ende MC van den, Richardson L, Kellner A (1978) Non-A, non-B hepatitis: identification of a virus-specific antigen and antibody: a preliminary report. In: Vyas GN, Cohen SN, Schmid R (eds) Viral hepatitis. Franklin Institute Press, Philadelphia, pp. 633-640.
65. Prince AM, Brotman B, Huima T, Pascual D, Jaffery M, Inchauspé G (1992) Immunity in hepatitis C infection. J Infect Dis 165: 438
66. Purcell RH (1994) Hepatitis C virus: historical perspective and current concepts. FEMS Microbiol Rev 14: 181
67. Rehermann B, Chang K-M, McHutchison JG, Kokka R, Houghton M, Chisari FV (1996) Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest 98: 1432
68. Rehermann B, Chang KM, McHutchinson J, Kokka R, Houghton M, Rice CM (1996) Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol 70: 7092
69. Rice CM, Walker CM (1995) Hepatitis C virus-specific T lymphocyte responses. Curr Opin Immunol 7: 532
70. Rosa D, Campagnoli S, Moretto C, Guenzi E, Cousens L, Chin M (1996) A quantitative test to estimate neutralizing antibodies to the hepatitis virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci USA 93: 1759
71. Sansonno D, Dammacco F (1993) Hepatitis C virus ClOO antigen in liver tissue from patients with acute and chronic infection. Hepatology 18: 240
72. Scarselli E, Cerino A, Esposito G, Silini E, Mondelli MU, Traboni C (1995) Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients. J Virol 69: 4407
73. Schlauder GG, Leverenz GJ, Amann CW, Lesniewski RR, Peterson DA (1991) Detection of the hepatitis C virus genome in acute and chronic experimental infection in chimpanzees. J Clin Microbiol 29: 2175
74. Schupper H, Hayashi P, Scheffel J, Aceituno S, Paglieroni T, Holland PV (1993) Peripheral-blood mononuclear cell responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C. Hepatology 18: 1055
75. Seeff LB (1995) Natural history of viral hepatitis, type C. Semin Gastrointest Dis 6: 20
76. Shimizu YK, Feinstone SM, Purcell RH, Alter HJ, London WT (1979) Non-A, non-B hepatitis: ultrastructural evidence for two agents in experimentally infected chimpanzees. Science 205: 197
77. Shimizu YK, Weiner AJ, Rosenblatt J, Wong DC, Shapiro M, Popkin T, Houghton M, Alter HJ, Purcell RH (1990) Early events in hepatitis C virus infection of chimpanzees. Proc Natl Acad Sci USA 87: 6441
78. Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H (1994) Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol 68: 1494
79. Shimizu YK, Feinstone SM, Kohara M, Purcell RH, Yoshikura H (1996) Hepatitis C virus: detection of intracellular virus particles by electron microscopy. Hepatology 23: 205
80. Shindo M, Di Bisceglie AM, Biswas R, Mihalik K, Feinstone SM (1992) Hepatitis C virus replication during acute infection in the chimpanzee. J Infect Dis 166: 424
81. Shirai M, Okada H, Nishioka M, Akatsuka T, Wychowski C, Houghten R (1994) An epitope in hepaliüs C virus core region recognized by cytotoxic T cells in mice and humans. J Virol 68: 3334
82. Tabor E, Gerety RJ, Drucker JA, Seeff LB, Hoofnagle JH, Jackson DR, April M, Barker LF, Pineda-Tamondong G (1978) Transmission of non-A, non-B hepatitis from man to chimpanzee. Lancet I: 463
83. Tabor E, Seeff LB, Gerety R (1980) Chronic non-A, non-B hepatitis carrier state. Transmissible agent documented in one patient over a six year period. N Engl J Med 303: 139
84. Tabor E, Purcell RH, Gerety RJ (1983) Primate animal models and titered inocula for the study of human hepatitis A, hepatitis B, and non-A, non-B hepatitis. J Med Primatol 1: 305
85. Taniguchi S, Okamoto H, Sakamoto M (1993) A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. Virology 195: 297
86. Tsai S-L, Chen P-J, Hwang L-H, Kao J-H, Huang J-H, Chang T-H (1994) Immune response to a hepatitis C virus nonstructural protein in chronic hepatitis C virus infection. J Hepatol 21: 403
87. Van Doorn LJ, Capriles I, Maertens G, DeLeys R, Murray K, Kos T (1995) Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses. J Virol 69: 773
88. Wang Y-F, Brotman B, Andrus L, Prince AM (1996) Immune response to epitopes of hepatitis C virus (HCV) structural proteins in HCV-infected humans and chimpanzees. J Infect Dis 173: 808
89. Weiner AJ, Geysen HM, Christopherson C (1992) Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci USA 89: 3468
90. Weiner A, Erickson AL, Kansopon J, Crawford K, Muchmore E, Hughes AL, Houghton M, Walker CM (1995) Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc Natl Acad Sci USA 92: 2755
91. Wentworth PA, Sette A, Celis E, Sidney J, Southwood S, Crimi C (1996) Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome. Int Immunol 8: 651
92. Yang P-M, Hwang L-H, Lai M-Y, Huang W-L, Chu Y-D, Chi W-K (1995) Prominent proliferative response of peripheral blood mononuclear cells to a recombinant non-structural (NS3) protein of hepatitis C virus in patients with chronic hepatitis C. Clin Exp Immunol 101: 272
93. Zibert A, Schreier E, Roggerndorf M (1995) Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 208: 653